CSIMarket
Eli Lilly And Company  (LLY)
Other Ticker:  
 
 

Eli Lilly's Yearly Income from Continued Operations Growth 5 Years

 

Select the Comparisons : Select the Ratio:



LLY Annual Income from Cont. Operations Growth

2023
2022
2021
2020
2019
Y / Y Annual Income from Cont. Operations Change -16.08 % 11.88 % -9.88 % 33.55 % 43.5 %
Annual Income from Cont. Operations (in millions $) $5,240.40 $6,244.80 $5,581.70 $6,193.70 $4,637.90


Annual Income from Cont. Operations Growth Comment
Eli Lilly And Company experienced detoriation of Annual Income from Cont. Operations for the fiscal year ended 2023 by -16.08% to $ 5,240.40 millions, compare to $ 6,244.80 in Annual Income from Cont. Operations reported in the previous year. The decline in company's annual Income from Continued Operations accelerated, from the 11.88 % gain, in the fiscal year ended 2022.

Eli Lilly Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2023 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2023 Annual Income from Cont. Operations
Pfizer Inc -93.08 %$ 2,173.000  millions
Johnson and Johnson -25.72 %$ 13,326.000  millions
Biontech Se -90.14 %$ 1,041.936  millions
Novartis Ag  113.57 %$ 14,854.000  millions
Biogen Inc -60.78 %$ 1,161.500  millions
Zoetis Inc   10.85 %$ 2,340.000  millions
Takeda Pharmaceutical Company Limited  30.34 %$ 2,196.436  millions
Becton Dickinson And Company -6.42 %$ 1,530.000  millions
Edwards Lifesciences Corporation -8.05 %$ 1,399.400  millions
Intuitive Surgical Inc   35.18 %$ 1,817.300  millions
Agilent Technologies inc -1.12 %$ 1,240.000  millions
Iqvia Holdings Inc   24.47 %$ 1,358.000  millions
Quest Diagnostics Inc -10.54 %$ 908.000  millions
Fresenius Medical Care Ag -18.10 %$ 820.353  millions
Tenet Healthcare Corp  31.10 %$ 1,311.000  millions
Organon and Co   11.56 %$ 1,023.000  millions
Mettler toledo International Inc -9.60 %$ 788.778  millions
Resmed Inc   15.15 %$ 897.556  millions
Davita Inc   24.58 %$ 956.978  millions
United Therapeutics Corporation  35.40 %$ 984.800  millions
Boston Scientific Corporation  128.08 %$ 1,592.000  millions
Idexx Laboratories Inc  24.44 %$ 845.042  millions
West Pharmaceutical Services Inc   1.28 %$ 593.400  millions
Vir Biotechnology Inc